310 related articles for article (PubMed ID: 28378549)
21. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
22. [Myxoid variant of adrenocortical carcinoma].
Jeremie G; Lifante JC; Chazot FB; Sajous C; Raymond P; Decaussin-Petrucci M
Ann Pathol; 2021 Apr; 41(2):186-191. PubMed ID: 33549334
[TBL] [Abstract][Full Text] [Related]
23. Adrenocortical neoplasia: evolving concepts in tumorigenesis with an emphasis on adrenal cortical carcinoma variants.
de Krijger RR; Papathomas TG
Virchows Arch; 2012 Jan; 460(1):9-18. PubMed ID: 22086150
[TBL] [Abstract][Full Text] [Related]
24. Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia.
Weissferdt A; Phan A; Suster S; Moran CA
Am J Clin Pathol; 2013 Jun; 139(6):780-6. PubMed ID: 23690121
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database.
Tella SH; Kommalapati A; Yaturu S; Kebebew E
J Clin Endocrinol Metab; 2018 Sep; 103(9):3566-3573. PubMed ID: 29982685
[TBL] [Abstract][Full Text] [Related]
26. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract][Full Text] [Related]
27. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.
Pennanen M; Heiskanen I; Sane T; Remes S; Mustonen H; Haglund C; Arola J
Hum Pathol; 2015 Mar; 46(3):404-10. PubMed ID: 25582500
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study.
Souteiro P; Donato S; Costa C; Pereira CA; Simões-Pereira J; Oliveira J; Belo S; Santos AP; Cardoso H; Leite V; Carvalho D; Torres I
Hormones (Athens); 2020 Jun; 19(2):197-203. PubMed ID: 31823340
[TBL] [Abstract][Full Text] [Related]
29. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.
Kerkhofs TM; Verhoeven RH; Bonjer HJ; van Dijkum EJ; Vriens MR; De Vries J; Van Eijck CH; Bonsing BA; Van de Poll-Franse LV; Haak HR;
Eur J Endocrinol; 2013 Jul; 169(1):83-9. PubMed ID: 23641018
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
31. A novel case of myxoid variant of adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.
Harada K; Yasuda M; Hasegawa K; Yamazaki Y; Sasano H; Otsuka F
Endocr J; 2019 Aug; 66(8):739-744. PubMed ID: 31118348
[TBL] [Abstract][Full Text] [Related]
32. A Case Report of Bilateral Sarcomatoid Carcinoma of Adrenal Glands With Adrenal Insufficiency.
Ishikawa N; Nagase M; Takami S; Araki A; Ishikawa N; Koike C; Shiina H; Maruyama R
Int J Surg Pathol; 2016 Dec; 24(8):743-748. PubMed ID: 27353077
[TBL] [Abstract][Full Text] [Related]
33. Surgical management and clinical prognosis of adrenocortical carcinoma.
Dong D; Li H; Yan W; Ji Z; Mao Q
Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
[TBL] [Abstract][Full Text] [Related]
34. Sarcomatoid Adrenal Carcinoma: Case Report with Contribution to Pathogenesis.
Saeger W; Mohren W; Behrend M; Iglauer P; Wilczak W
Endocr Pathol; 2017 Jun; 28(2):139-145. PubMed ID: 27688079
[TBL] [Abstract][Full Text] [Related]
35. [RESULTS OF DIAGNOSTICS AND TREATMENT OF ADRENOCORTICAL CANCER].
Romashchenko PN; Maĭstrenko NA; Orlova RV; Babich AI
Vestn Khir Im I I Grek; 2015; 174(3):29-39. PubMed ID: 26390585
[TBL] [Abstract][Full Text] [Related]
36. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
37. Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database.
Canter DJ; Mallin K; Uzzo RG; Egleston BL; Simhan J; Walton J; Smaldone MC; Master VA; Bratslavsky G; Kutikov A
Can J Urol; 2013 Oct; 20(5):6915-21. PubMed ID: 24128829
[TBL] [Abstract][Full Text] [Related]
38. Challenges in surgical pathology of adrenocortical tumours.
Erickson LA
Histopathology; 2018 Jan; 72(1):82-96. PubMed ID: 29239032
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan.
Nakanishi S; Fukushima Y; Inokuchi J; Hakariya T; Kakinoki H; Enokida H; Chikui K; Matsuoka H; Shin T; Mukai S; Kamba T; Eto M; Imamura R; Noguchi M; Igawa T; Haga N; Kamoto T; Fujimoto N; Saito S
Int J Urol; 2024 May; 31(5):484-491. PubMed ID: 38193650
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
